INTERDISCIPLINARY COOPERATION IN PREVENTIVE PROCEDURES OF OSTEONECROSIS OF THE JAW BONE IN PATIENTS TREATED WITH BISPHOSPHONATES

被引：0
|
作者：
Kovalova, Eva [1 ]
Klamrova, Tatiana
Eliasova, Anna
Novak, Bohuslav
机构：
[1] Presov Univ, Fac Hlth, Parizanska 1, Presov 08001, Slovakia
来源：
HEALTH PROBLEMS OF CIVILIZATION | 2015年 / 9卷 / 04期
关键词：
bisphosphonates; osteonecrosis of the jaw bone; risk patients in dental hygiene;
D O I：
10.5114/hpc.2015.57702
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
Objective: The authors submitted a proposal of preventive procedures to eliminate the risks of osteonecrosis of the jaw bone in patients treated with bisphosphonates using interdisciplinary cooperation of specialists. Conclusion: Before starting the treatment of bone metastases with bisphosphonates, all patients should have dental examination, dental treatment and dental hygiene treatment as a prevention of osteonecrosis of the jaw bone. The application of preventive approaches can reduce risk and eliminate the incidence of osteonecrosis of the jaw in patients who have to take bisphosphonates.
引用
收藏
页码：49 / 53
页数：5
相关论文
共 50 条
  • [31] Osteonecrosis of the jaw related to bisphosphonates, denosumab and anti-angiogenics in cancer and osteoporotic patients: prevention and safety of dental procedures
    Campisi, G.
    Bedogni, A.
    Di Fede, O.
    Vescovi, P.
    Fusco, V.
    Lo Muzio, L.
    DENTAL CADMOS, 2013, 81 (10) : 634 - 649
  • [32] Osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates: how the knowledge of a phenomenon can change its evolution
    La Verde, Nicla
    Bareggi, Claudia
    Garassino, Marina
    Borgonovo, Karen
    Sburlati, Paola
    Pedretti, Donata
    Bianchi, Celso
    Perrone, Silvia
    Mihali, Dorian
    Cobelli, Stefano
    Mantica, Cristina
    Rizzo, Aurora
    Farina, Gabriella
    SUPPORTIVE CARE IN CANCER, 2008, 16 (11) : 1311 - 1315
  • [33] Jaw Osteonecrosis Associated with Use of Bisphosphonates and Chemotherapy: Paradoxical Complication of Treatment of Bone Lesions in Multiple Myeloma Patients
    Silvana Capalbo
    Mario Delia
    Daniela Diomede
    Michelina Dargenio
    Antonia Chiefa
    Gianfranco Favia
    Vincenzo Liso
    International Journal of Hematology, 2006, 83 : 439 - 442
  • [34] Jaw osteonecrosis associated with use of bisphosphonates and chemotherapy: Paradoxical complication of treatment of bone lesions in multiple myeloma patients
    Capalbo, S
    Delia, M
    Diomede, D
    Dargenio, M
    Chiefa, A
    Favia, G
    Liso, V
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2006, 83 (05) : 439 - 442
  • [35] Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates
    A. Sánchez
    R. Blanco
    Osteoporosis International, 2017, 28 : 1145 - 1147
  • [36] Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates
    Sanchez, A.
    Blanco, R.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 (03) : 1145 - 1147
  • [37] Preventive Strategies for Patients at Risk of Medication-related Osteonecrosis of the Jaw
    Goodday, Reginald H.
    ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA, 2015, 27 (04) : 527 - +
  • [38] Prophylaxis of osteonecrosis in the case of patients treated with bisphosphonates: A review paper
    Nieckula, Pawel
    Stempniewicz, Anna
    Tubaja, Monika
    DENTAL AND MEDICAL PROBLEMS, 2018, 55 (04) : 425 - 429
  • [39] Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid
    Dimopoulos, M. A.
    Kastritis, E.
    Bamia, C.
    Melakopoulos, I.
    Gika, D.
    Roussou, M.
    Migkou, M.
    Eleftherakis-Papaiakovou, E.
    Christoulas, D.
    Terpos, E.
    Bamias, A.
    ANNALS OF ONCOLOGY, 2009, 20 (01) : 117 - 120
  • [40] Osteonecrosis of the jaw induced by bisphosphonates therapy in bone metastases patient: Case report and literature review
    Hao, Lei
    Tian, Zhuoli
    Li, Shanli
    Yan, Kemin
    Xue, Yan
    ORAL ONCOLOGY, 2022, 128
12345